Literature DB >> 11050668

Abnormalities of glucose metabolism in spontaneously hypertensive rats.

L M Gouveia1, I C Kettelhut, M C Foss.   

Abstract

Abnormalities in glucose metabolism and insulin action are frequently detected in patients with essential hypertension. Spontaneously hypertensive rats (SHR) have been used as an experimental model to understand this pathological condition. The objective of the present study was to assess glucose metabolism and insulin action in SHR and Wistar rats under fed and fasting conditions. Peripheral glucose utilization was estimated by kinetic studies with [6-(3)H]-glucose and gluconeogenetic activity was measured during continuous [(14)C]-bicarbonate infusion. Plasma glucose levels were higher in the SHR group. Plasma insulin levels in the fed state were higher in the SHR group (99.8 +/- 6.5 microM) than in the control group (70.4 +/- 3.6 microM). Muscle glycogen content was reduced in SHR compared to control under the various experimental conditions. Peripheral glucose utilization was slightly lower in the SHR group in the fed state (8.72 +/- 0.55 vs 9.52 +/- 0.80 mg kg(-1) min(-1) in controls). Serum free fatty acid levels, hepatic glycogen levels, hepatic phosphoenolpyruvate carboxykinase activity and gluconeogenetic activity were similar in the two groups. The presence of hyperglycemia and hyperinsulinemia and the slightly reduced peripheral glucose utilization suggest the presence of resistance to the action of insulin in peripheral tissues of SHR. Hepatic gluconeogenesis does not seem to contribute to the metabolic alterations detected in these animals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050668     DOI: 10.1590/s0100-879x2000001100015

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  4 in total

Review 1.  Risk of postprandial insulin resistance: the liver/vagus rapport.

Authors:  Maria Paula Macedo; Inês S Lima; Joana M Gaspar; Ricardo A Afonso; Rita S Patarrão; Young-Bum Kim; Rogério T Ribeiro
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

2.  Angiotensin II or epinephrine hemodynamic and metabolic responses in the liver of L-NAME induced hypertension and spontaneous hypertensive rats.

Authors:  Debora Conte Kimura; Marcia Regina Nagaoka; Durval Rosa Borges; Maria Kouyoumdjian
Journal:  World J Hepatol       Date:  2017-06-18

3.  Experimental Activation of Endocannabinoid System Reveals Antilipotoxic Effects on Cardiac Myocytes.

Authors:  Ewa Harasim-Symbor; Agnieszka Polak-Iwaniuk; Karolina Konstantynowicz-Nowicka; Patrycja Bielawiec; Barbara Malinowska; Irena Kasacka; Adrian Chabowski
Journal:  Molecules       Date:  2020-04-21       Impact factor: 4.411

4.  GLP1R Attenuates Sympathetic Response to High Glucose via Carotid Body Inhibition.

Authors:  Audrys G Pauza; Pratik Thakkar; Tatjana Tasic; Igor Felippe; Paul Bishop; Michael P Greenwood; Kristina Rysevaite-Kyguoliene; Julia Ast; Johannes Broichhagen; David J Hodson; Helio C Salgado; Dainius H Pauza; Nina Japundzic-Zigon; Julian F R Paton; David Murphy
Journal:  Circ Res       Date:  2022-02-01       Impact factor: 17.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.